跳至主要内容
临床试验/NCT05318248
NCT05318248已完成不适用

The Role of Stress Neuromodulators in Decision Making Under Risk

Charite University, Berlin, Germany1 个研究点 分布在 1 个国家目标入组 82 人开始时间: 2022年3月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
82
试验地点
1
主要终点
Working Memory (n-back task)

研究概览

简要总结

The aim of the proposed project is to combine precise pharmacological manipulation of the noradrenergic system with behavioral modeling of memory processes, and fMRI methods to study the effect of a pharmacologically induced blockade of the noradrenergic system on memory processes. Behaviorally, the investigators will focus on the effect of the noradrenergic blockade on working memory performance, and recognition memory.

详细描述

Affective states like acute stress can influence cognition, i.e., memory processes. Physiologically, acute stress elicits an array of autonomic and endocrine responses, including a fast release of norepinephrine from the locus coeruleus noradrenergic (LC NA) system. Compelling evidence shows that in healthy humans, stimulation of the noradrenergic system increases memory performance whereas noradrenergic blockade reduces memory performance. Functional magnetic resonance imaging (fMRI) studies have shown that manipulations of the noradrenergic system affects responsiveness and connectivity within networks that are important for autonomic-neuroendocrine control and temporal and spatial attention orientation. So far, no study investigated the neural underpinnings of memory processes after a pharmacologically induced noradrenergic blockade. The aim of the proposed project is to combine precise pharmacological manipulation of the noradrenergic system with behavioral modeling of distinct memory processes, and fMRI methods to study the effect of a pharmacologically induced blockade of the noradrenergic system on two distinct memory processes. Behaviorally, the investigators will focus on the effect of the noradrenergic blockade on working memory performance, and recognition memory. Participants are randomly assigned to one of two groups: (A) clonidine, or (B) placebo.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 40 Years(Adult)
性别
Male
接受健康志愿者

入选标准

  • right handed, high-school diploma

排除标准

  • former & present DSM-5 axis I disorders, medication,

研究组 & 干预措施

Clonidin

Experimental

pill 0,15 mg clonidin

干预措施: Clonidin (Drug)

Placebo

Placebo Comparator

placebo pill

干预措施: Placebo (Drug)

结局指标

主要结局

Working Memory (n-back task)

时间窗: 11 minutes

Behavioral outcome of emotional two-back task = number of correct answers / button presses

Recognition Memory (word list learning)

时间窗: 25 minutes

Behavioral outcome of word recognition task = number of correctly recognized words

Blood-oxygen-level-dependent (BOLD) response

时间窗: 46 minutes

fMRI data

次要结局

  • salivary cortisol(2.5 hours)
  • blood pressure(2.5 hours)
  • Heart rate(2.5 hours)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Katja Wingenfeld

Prof. Dr.

Charite University, Berlin, Germany

研究点 (1)

Loading locations...

相似试验